lindner

The effects of Abciximab use on both survival and cardiac billing.

data

Implements novel nonparametric approaches to address
biases and confounding when comparing treatments or exposures in
observational studies of outcomes. While designed and appropriate for use
in studies involving medicine and the life sciences, the package can be
used in other situations involving outcomes with multiple confounders.
The package implements a family of methods for non-parametric bias correction
when comparing treatments in observational studies, including survival
analysis settings, where competing risks and/or censoring may be present.
The approach extends to bias-corrected personalized predictions of treatment
outcome differences, and analysis of heterogeneity of treatment effect-sizes
across patient subgroups. For further details, please see:
Lauve NR, Nelson SJ, Young SS, Obenchain RL, Lambert CG. LocalControl:
An R Package for Comparative Safety and Effectiveness Research.
Journal of Statistical Software. 2020. p. 1<e2><80><93>32. Available from <doi:10.18637/jss.v096.i04>.

Christophe Lambert

LocalControl

Nonparametric Methods for Generating High Quality Comparative
Effectiveness Evidence

Nicolas R. Lauve

Stuart J. Nelson

S. Stanley Young

Robert L. Obenchain

Melania Pintilie

Martin Kutz

Christophe G. Lambert

lindner function

A data frame with 996 rows and 10 columns:<dl class="dl-horizontal">
 <dt>lifepres</dt><dd>Life years preserved post treatment: 0 (died) vs. 11.6 (survived).</dd>
 <dt>cardbill</dt><dd>Cardiac related billing in dollars within 12 months.</dd>
 <dt>abcix</dt><dd>Indicates whether the patient received Abciximab treatment: 1=yes 0=no.</dd>
 <dt>stent</dt><dd>Was a stent depolyed? 1=yes, 0=no.</dd>
 <dt>height</dt><dd>Patient height in centimeters.</dd>
 <dt>female</dt><dd>Patient sex: 1=female, 0=male.</dd>
 <dt>diabetic</dt><dd>Was the patient diabetic? 1=yes, 0=no.</dd>
 <dt>acutemi</dt><dd>Had the patient suffered an acute myocardial infarction witih the last seven days? 1=yes, 0=no.</dd>
 <dt>ejecfrac</dt><dd>Left ventricular ejection fraction.</dd>
 <dt>ves1proc</dt><dd>Number of vessels involved in the first PCI procedure.</dd>
</dl>

Format

Lindner Center for Research and Education study on Abciximab cost-effectiveness and survival — lindner

A data frame with 996 rows and 10 columns:<dl class='dl-horizontal'>
 <dt>lifepres</dt><dd>Life years preserved post treatment: 0 (died) vs. 11.6 (survived).</dd>
 <dt>cardbill</dt><dd>Cardiac related billing in dollars within 12 months.</dd>
 <dt>abcix</dt><dd>Indicates whether the patient received Abciximab treatment: 1=yes 0=no.</dd>
 <dt>stent</dt><dd>Was a stent depolyed? 1=yes, 0=no.</dd>
 <dt>height</dt><dd>Patient height in centimeters.</dd>
 <dt>female</dt><dd>Patient sex: 1=female, 0=male.</dd>
 <dt>diabetic</dt><dd>Was the patient diabetic? 1=yes, 0=no.</dd>
 <dt>acutemi</dt><dd>Had the patient suffered an acute myocardial infarction witih the last seven days? 1=yes, 0=no.</dd>
 <dt>ejecfrac</dt><dd>Left ventricular ejection fraction.</dd>
 <dt>ves1proc</dt><dd>Number of vessels involved in the first PCI procedure.</dd>
</dl>

Lindner Center for Research and Education study on Abciximab cost-effectiveness and survival

lindner: Lindner Center for Research and Education study on Abciximab cost-effectiveness and survival

Description

Arguments

Format

References